Maria Lia Palomba MD

Oncology•New York, NY

Hematologic Oncology

Professor, Medicine, Weill Cornell Medical College

Request appointment

530 East 74th StreetNew York, NY 10021
Book by Phone+1(765) 405-2710

Overview of Dr. Palomba

Dr. Maria Palomba is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and New York-Presbyterian Hospital. She received her medical degree from University of Pavia Faculty of Medicine and has been in practice 39 years. Dr. Palomba accepts several types of health insurance, listed below. She is one of 537 doctors at Memorial Sloan Kettering Cancer Center and one of 68 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. She also speaks multiple languages, including Italian. She has more than 100 publications and over 500 citings.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Mount Auburn HospitalResidency, Internal Medicine, 1997 - 1999
University of Pavia Faculty of MedicineClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 2002 - 2027
CT State Medical License 2023 - 2026
NC State Medical License 2020 - 2022

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017

Clinical Trials

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
COMPLETED
PHASE1
IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
COMPLETED
PHASE1
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL Start of enrollment: 2021 May 21
ACTIVE_NOT_RECRUITING
PHASE2

Publications & Presentations

PubMed

CD20 re-emergence in a patient with diffuse large B-cell lymphoma who experienced a CD20-negative relapse after glofitamab treatment.
Pranya Gaddipati, Ahmed Ayad, Zachary Epstein-Peterson, Maria Lia Palomba, Mia Catillo
Haematologica. 2026-10-01
Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma.
Robert Stuver, Esther Drill, Laure Michaud, Carla Casulo, Ranjana H Advani
Haematologica. 2026-10-01
1 citations
Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Beatriz Wills, Sarah Samorodnitsky, Samantha Brown, Jessica R Flynn, Sean Devlin
Transplantation and Cellular Therapy. 2026-10-01

Journal Articles

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
Jeffrey V Matous, M Lia Palomba, Steven P Treon, The New England Journal of Medicine

Abstracts/Posters

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Includi...
Maria Lia Palomba, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
Maria Lia Palomba, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cel...
Maria Lia Palomba, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Fast and Furious Cars: Looking Ahead to Next-Generation Treatments and New Combinations
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Atezolizumab in Combination with Obinutuzumab and Lenalidomide Demonstrates Favorable Activity and Manageable Toxicity in Patients with Relapsed/Refractory Follicular ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL “Armored” CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Tr...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Will You Be Attending “A Shifting Landscape: Treatment of MCL” at ASH?December 3rd, 2024

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Italian

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment